Group items matching

in title, tags, annotations or url

The St. Baldrick's Foundation works hard to be sure that every dollar makes the biggest impact possible in childhood cancer research. The Foundation has held several Research Priorities Summits with many of the country's leading pediatric oncology researchers participating to advise the staff and board of directors on funding priorities. The St. Baldrick's team and Scientific Advisors meet regularly to be sure St. Baldrick's funds make the greatest impact on pediatric cancer research. Current funding priorities are divided into four categories: * New discovery research * Translational research and early phase clinical trials * Phase III clinical trials & infrastructure support of participating institutions (primarily the fall grant cycle) * Education of new pediatric oncology researchers In addition to research to understand the biology of childhood cancers and discover leads to more effective treatments, topics of interest include, but are not limited to: * Adolescents & young adults * Survivorship, outcomes, and quality of life * Supportive care * Epidemiology and pediatric cancer predispositions * Precision medicine * Alternative & complementary therapies

The purpose of this notice of funding opportunity (NOFO) is to support a research project that aims to develop and implement an influenza-like illness (ILI)-specific student absentee monitoring system in kindergarten through twelfth grade (K-12) schools and assess its usability for early detection of influenza, SARS-CoV-2, and other respiratory pathogen transmission in schools and surrounding communities. To achieve this aim, the project team will: 1) rapidly determine the causes of school absenteeism in students across selected school district(s) over a three-year period; 2) detect within-household transmission of influenza and SARS-CoV-2 in households from which a student has been absent from school due to ILI; and 3) assess comparability between influenza-specific and SARS-CoV-2-specific student absenteeism data from the participating schools and multiple layers of complementary influenza and SARS-CoV-2 surveillance data routinely collected in the health care facilities serving the general population of this school district.

The ASPEN Rhoads Research Foundation, the philanthropic arm of the American Society for Parenteral and Enteral Nutrition, is dedicated to improving patient care by advancing the science and practice of clinical nutrition and metabolism. Founded in 1976, ASPEN is an interdisciplinary organization whose members are involved in the provision of clinical nutrition therapies, including parenteral and enteral nutrition. With more than sixty-five hundred members from around the world, ASPEN is a community of dietitians, nurses, pharmacists, physicians, scientists, students, and other health professionals from every facet of nutrition support clinical practice, research, and education. To advance its mission, the foundation is accepting applications for its ASPEN Rhoads Research Foundation Grants program. Through the annual program, grants of up to $25,000 will be awarded for research projects by early-career investigators focused on clinical nutrition and metabolic support in alignment with the priorities outlined in the ASPEN Research Agenda.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage innovative health services research that can directly and demonstrably contribute to the improvement of minority health and/or the reduction of health disparities at the health care system-level as well as within clinical settings.

This notice announces the opportunity to apply for funding under the MCH Navigator Program. The purpose of this program is to serve as a learning portal of high-quality vetted, MCH Leadership Competency-based trainings and resources to strengthen the knowledge, skills, and capacity of the MCH workforce through online continuing education (CE) tailored to meet the needs of emerging and practicing MCH professionals. This program supports HRSA Strategic Plan 2019-2022 goals to improve access to quality health care and services, strengthen the health workforce, and improve health equity. The specific objectives of the MCH Navigator Program are to support the workforce by: (1) assessing and addressing the state of knowledge and skills in the MCH community; (2) increasing knowledge and skills of the MCH workforce and students; (3) providing access to high-quality, relevant, accessible trainings; (4) developing innovative website features and enhancements1; and (5) collaborating with state Title V, local public health staff, and key MCH organizations.

Despite the growing interest and rapid pace of recent achievements, not much is known with a high degree of confidence about the strategies and interventions that might reduce diagnostic failures and patient harms or enhance the resilience and safety of diagnostic work. This Funding Opportunity Announcement (FOA) solicits applications from research institutions and their investigators to conduct Health Services Research Demonstration and Dissemination Projects (R18) to evaluate strategies and interventions for reducing diagnostic failures and patient harms, including approaches that enable organizations, providers and patients to better anticipate emerging diagnostic risk before failure and harm occurs.

The purpose of the program is to enhance and/or expand the capacity of substance use disorder treatment providers to serve youth and adults with substance use disorders or co-occurring substance use and mental disorders who have been underserved and/or have special needs (e.g., elderly, ethnic and racial minorities, criminal justice involved individuals, etc.). This is referred to as the "population of focus."

The purpose of this funding opportunity announcement is to support a practice-based research network in the United States to transform the development, delivery, and sustainability of evidence-based mental health practices and services. Through a research consortium embedded within large and integrated healthcare delivery systems (public and/or commercial systems) that serve representative populations, this Network would result in a continuously learning healthcare system as defined by the Institute of Medicine, to create a continuous cycle or feedback loop in which scientific evidence informs clinical practice while data gathered from clinical practice and administrative sources inform scientific investigation.

The purpose of this research project is to use medical and pharmacy claims data in real-time to: 1) identify HIV-infected patients who have stopped filling anti-retroviral (ARV) prescriptions and to target these individuals for adherence and retention intervention(s) (Category A); and 2) identify persons living with HIV (including pregnant women) and to ensure these individuals are receiving ARV therapy - Medical and Pharmacy Claims (Category B).

The objective of this FOA is to advance non-sputum-based tuberculosis (TB) diagnostics for use in HIV-1 infected and HIV-1 exposed uninfected children (HEU) for improved, simplified, rapid and decentralized diagnosis of TB disease. This opportunity will support discovery and validation of novel biomarkers useful for TB diagnosis or the development/optimization and early validation of novel TB diagnostic technologies.

This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of novel and supportive technologies for the improvement of cell replacement interventions using novel methods, biomaterials and devices for type 1 diabetes (T1D) treatment.

The purpose of this funding opportunity announcement (FOA) is to stimulate research to examine the multi-dimensional foundations, experiences and management of complex, advanced signs and symptoms at the end of life.

DHAPP's goal is to maximize program impact by focusing on the drivers of the HIV epidemic specific to the military and to support the development of interventions and programs that address these issues. DHAPP works with militaries of foreign countries to devise plans

The HPNF Certification Research Grant is intended to provide investigators with resources to conduct exploratory, pilot, or feasibility studies that will lead to larger-scale projects linking certification with patient outcomes. Examples include the collection of preliminary data about the distribution of certification qualifications among staff of different types of organizations or the analysis of data sets from healthcare systems for patterns of staffing and outcomes.

This FOA will support research to test approaches in the healthcare setting to using Patient-Reported Outcomes (PROs) as tools to enhance patient-centered treatment and improve outcomes in individuals with type 1 diabetes.

The aim of the CDA is to support the next generation of researchers and to significantly improve outcomes and quality of life for breast cancer patients. The award will provide up to $100,000 per year for two years to be combined with matching funds or in kind contribution from the applicant's institution. Neither ASTRO nor BCRF will pay indirect costs as part of this award. One award will be funded. Research must be focused on understanding or treatment of breast cancer and include use or impact of radiation treatment.

The aim of the CDA is to support the next generation of researchers and to significantly improve outcomes and quality of life for prostate cancer patients. The award will provide up to $75,000 per year for three years to be combined with matching funds or in kind contribution from the applicant's institution. Neither ASTRO nor PCF will pay indirect costs as part of this award. One award will be funded. Research must be focused on understanding or treatment of prostate cancer and include use or impact of radiation treatment.

The key element of the national HIV/AIDS program is ART scale up contributing towards strategic goals of treatment cascade. This project will build on the successful creation of a HIV medical information system through the ACCESS project by scaling up implementation of the MIS to treatment sites in all 12 PEPFAR focus oblasts, including capacity building of healthcare workers, improving information management, analysis and use. The project will also develop and implement a laboratory information system module. In addition, the project will work with the treatment sites to implement quality improvement and facility index testing activities in coordination with other PEPFAR and Global Fund supported activities. The major expected project results are 1) functional HIV MIS is operated by a GOU affiliated Operator at treatment sites in the 12 PEPFAR priority regions and Vinnitsa; 2) MIS data used by sites, GoU, PEPFAR , and other stakeholders; 3) laboratory module implemented; 3) quality improvement activities are implemented at all supported treatment sites; 4) high coverage facility index testing is performed at supported sites.

This Funding Opportunity Announcement (FOA) encourages applications that develop and test multilevel interventions to improve follow-up to abnormal screening tests for breast, cervical, colorectal, or lung cancers. Improving follow-up to abnormal screening tests is dependent on factors at the patient, provider, clinical team, clinic, healthcare institution, or community setting levels. Appropriate applications for this FOA should propose to intervene at two or more levels, and measure outcomes at three or more levels, while accounting for interactions that occur between and across levels.